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Neural tube defects (NTD) comprise of a group of congenital malformations that include spina 
bifida, anencephaly and encephalocele. Reports have implicated zinc deficiency as one of the 
causative factors of NTDs. We compared the serum zinc level of 23 newborns having neural tube 
defects with 35 healthy controls by spectrophotometery during 2003-2004. Zinc deficiency was 
documented in 43.5% of the cases and 8.6% of the controls (P = 0.002). Multivariate logistic 
regression analysis revealed a significant association between the presence of NTDs and zinc 
deficiency (OR = 8.2, 95% Cl: 1.9-34.7). 
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NEURAL tube defects (NTD) are an important cause of perinatal morbidity 
and mortality(1,2). The incidence varies from 
1/100 live births in certain regions of China to 
about 1/5000 live birth in Scandinavian 
countries(3). Etiology of NTD is considered 
multifactorial, with genetic, environmental 
and nutritional factors in all playing some 
role(4-6). 
Maternal zinc deficiency may play a role in 
causation of NTD in the offspring(8). Studies 
have also documented low serum zinc levels in 
neonates born with neural tube defects(9). We 
conducted this study to look for an association 
of zinc deficiency and neural tube defects in 
North-East area of Iran, which has a high 
prevalence of neural tube defects. 
Subjects and Methods 
This hospital based case control study was 
conducted during 2003-04 at the Dezyani 
hospital in Gorgan located in the north of Iran. 
The sample population consisted of 23 
newborns with NTD and 35 normal newborns 
selected at convenience. Data were collected 
regarding the maternal age, exposure to drug 
during pregnancy, history of abortions, and 
parity. Anthropometry of the newborn was 
recorded as per standard techniques.
Peripheral blood sample was collected from all 
the newborns, serum was separated and 
analyzed for Zinc level by spectrophotometric 
method, using Randox Kit UR. Serum zinc 
level of less than 7.6 micro mol/L was used as 
the cut-off to label the individual as zinc-
deficient. Parental consent was obtained for 
the study along with a clearance from 
Institutional ethical committee(10). 
Categorical data were compared by Chi-
square and Fisher’s exact test. Mann Whitney 
U test and unpaired Student’s ‘t’ test were used 
for comparison of means. Presence of neural 
tube defect was considered as the dependent 
factor in multivariate logistics regression 
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TABLE I–Newborn Family History, Prenatal History and Newborn Charactristics 
Cases Control P- value 
(n = 23) (n = 35) 
Maternal age: Year (mean ± SD) 27.2 ± 6 25.7 ± 5.3 0.46§ 
Paternal age: Year (mean ± SD)   31.3 ± 6.3  29 ± 6 0.15§ 
Multiparity   (n) 5 (20) 6 (16.2) 0.70¶ 
Pervious abortion (n) 4 (16) 5 (13.5) 0.79¶ 
History of other congenital malformations 4 (10.8) 1 (4.3) 0.64† 
Newborn weight: gram (mean ± SD) 2865 ± 719 3439 ± 497 < 0.001* 
Newborn height: cm (mean ± SD)  47 ±  4.6 50 ± 2.5 0.005* 
Gestational age: week (mean ± SD) 36 ± 2. 5 38.5 ± 0.9 <0.0001§ 
Maternal exposure During 1st trimester (drug) (%) 7(28) 1(2.7) 0.006† 
§: based on Mann-Wittney U test; ¶: based on Pearson’s chi-square test; †: based on Fisher exact test; *: two 
independent sample ‘t’ test. 
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analysis. Independent factors included in the 
analysis were parity, history of abortions, 
maternal drug exposure, and zinc deficiency as 
dichotomous variables. Data were analysed 
using SPSS 11.5 and STATA SE/8. 
Results 
Baseline characterstics of the two groups 
are depicted in Table 1. The groups were 
matched for parental age, parity, and obstetric 
history. However, control group babies were 
heavier and lengthy as compared to the study 
groups. The gestation of babies with NTD was 
less as compared to that of controls. 
Serum zinc level (Mean ± SD) in NTD 
patients and normal newborns was 8 ± 3.9 
micro mol per liter (µmol/L) and 12.3 ± 4.7 
µmol/L, respectively. Overall 43.5% of 
patients and 8.6% of the controls in this study 
had zinc deficiency (P = 0.002). Multivariate 
logistic regression analysis showed an 
association between the presence of NTD and 
zinc deficiency (OR=8.2, 95% CI: 1.9-34.7) 
(Table II). 
Discussion 
The results from this study indicate that 
there is an association between NTD and zinc 
deficiency. These findings are similar with 
results from other researchers such as Velie et 
al in California(8), Groenen, et al., in 
Netherland(11), Cengiz, et al., in Turkey(12) 
and other studies(13,14). On other hand, 
Hombidgem, et al.(15), Nikolov, et al., in 
Sofiioi(16), Weekes, et al.(17) reported that 
there is no relation between zinc deficiency 
and NTD. Most studies reporting a relation 
between zinc level and NTD were based on the 
maternal zinc status; studies using newborn 
serum are limited. Some studies in Mexico(9), 
Netherland(11) and Turkey(18) have shown 
that serum and hair zinc status in newborns are 
associated with risk of NTD. Srinivas, et al., in 
India(19) reported that there is a relationship 
between low zinc levels in newborns hair with 
NTD, but no differences were found in the 
serum levels. It is possible that these 
differences are due to diverse methods of zinc 
analysis. 
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TABLE II–Logistic Regression Analysis of the Variables Included in the Study 
Risk factor Crude OR Adjusted OR 
(CI 95%) (CI 95%) 
Low levels of zinc 8.2 (1.9-34.7) 7 (1.5-32.7) 
Multiparity 1.3 (0.4-4.8) 1.2 (0.2-7.4) 
History of abortions 1.3 (0.6-2.9) 1(0.3-3.2) 
Maternal drug exposure 14 (1.6-122.7) 11.9 (1.2-118.2) 
during 1st trimester 
However, this study has certain limitation. 
Firstly, the study and control groups are not age 
and sex matched. Also, there are differences in 
anthropometry of the two groups which could 
have led to differences in zinc level. Also, 
maternal zinc status should also have been 
estimated. Some experts also feel that use of 
serum zinc as a measure of zinc nutriture itself 
in questionable. The selection of control is not 
random. 
Despite these limitations, we are able to 
show that there is an association between 
neural tube defect and low serum zinc level in 
the newborns. This finding focuses attention 
once again to the importance of nutritional 
factor in the etiology of neural tube defects. 
Further studies should be carried out to verify 
or prove the cause - effect relationship of zinc 
deficiency with NTD. 
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Key Message 
•	 Newborns having neural tube defects have lower serum zinc concentrations as compared 
to healthy controls. 
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